Black Diamond Therapeutics, Inc. (BDTX): Shares Outstanding

Annual figures by period end, from SEC filings.

57.14M
As of 2025-12-31
57.45M
As of 2026-06-30
+16.2%
3-year compound annual growth
+9.6%
5-year compound annual growth
2018-12-31: 2.17M2019-12-31: 2.24M2020-12-31: 36.08M2021-12-31: 36.23M2022-12-31: 36.43M2023-12-31: 51.65M2024-12-31: 56.64M2025-12-31: 57.14M57.14M
2018-12-31 Shares Outstanding (shares) 2025-12-31
Period endedShares OutstandingChange YoYSource filing
2025-12-3157.14M+0.9%2026-03-16, Balance as of period end
2024-12-3156.64M+9.7%2026-03-16, Balance as of period end
2023-12-3151.65M+41.7%2025-03-06, Balance as of period end
2022-12-3136.43M+0.6%2024-03-12, Balance as of period end
2021-12-3136.23M+0.4%2023-03-09, Balance as of period end
2020-12-3136.08Mn/m2022-03-17, Balance as of period end
2019-12-312.24M+2.9%2021-03-25, Balance as of period end
2018-12-312.17Mn/a2020-03-24, Balance as of period end